Tag: Ahammune
Ahammune Biosciences raises USD 5 million in series A funding led...
The recently raised funding will assist the company in conducting human clinical trials for its promising drug candidate in vitiligo patients
Ahammune Biosciences partners Veeda Clinical Research for first human studies of...
First-in-human (Phase 1) studies of Ahammune’s investigational new drug for vitiligo- AB1001 that targets pathways involved in triggering autoimmunity in skin are currently being conducted by Veeda Clinical Research at Ahmedabad, Gujarat